Adam Townsend
Chief Commercial Officer
Other
COO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Commercial Officer | $542,732 | $3,956,053 |
| 2023 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Commercial Officer | $484,577 | $3,714,246 |
| 2022 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Commercial Officer | $460,013 | $3,096,029 |
| 2021 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Commercial Officer | $448,269 | $2,640,819 |
| 2020 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Commercial Officer | $430,038 | $2,901,007 |
Executive changes
Earnings-call appearances
-
Apellis Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-09-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-06-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-03-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-01-08
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-10-05
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2023 Earnings Call2023-07-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-03-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-09-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2022 Earnings Call2022-06-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-03-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q4 FY2021 Earnings Call2022-01-10
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-09-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-06-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2021 Earnings Call2021-03-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q4 FY2020 Earnings Call2020-12-31
Apellis Pharmaceuticals, Inc. (APLS)